Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Hematology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
EAHAD 2026: Nine-Year Outcomes of Gene Therapy
February 2026
Nine-year data show sustained safety and reduced bleeding after gene therapy in haemophilia B, although enrichment for full viral capsids did not deliver clear clinical advantages.
Read more
13 Jan 2016
Lentiviral HSC Gene Therapy for Older Patients with X-Linked Severe Combined Immunodeficiency
Press brief by Suk See De Ravin, MD, PhD, at the American Society of Hematology (ASH) 2015 annual meeting. Dr De Ravin gives an overview of how…
12 Dec 2015
Northstar study: gene therapy for beta-thalassemia major using LentiGlobin BB305 drug product
Press brief by Mark C. Walters, MD, at the American Socitety of Hematology (ASH) 2015 annual meeting. Dr Walters provides an update on the Northstar…
12 Dec 2015
Infusion of allogeneic anti-CD19 CAR T-cells is a promising approach after alloHSCT
Press brief by James N. Kochenderfer, MD, at the American Socitety of Hematology (ASH) 2015 annual meeting. Dr Kochenderfer provides an overview of a…
24 Nov 2015
SCHILLER Enables the Export of ECG Raw Data: Resting ECGs, Exercise ECGs and Resting Rhythms
SCHILLER’s declared goal is to make therapy-relevant data accessible in digital form throughout the hospital. Thanks to the latest development, we have…
13 Aug 2015
New therapeutic approaches for Hodgkin lymphoma
At the 20th Congress of the European Hematology Association (EHA), Andrew Davies, BSc (Hons), BM (Hons), MRCP, PhD, of the University of Southampton…
13 Aug 2015
Novel monoclonal antibody-based therapies for multiple myeloma
At the 20th Congress of the European Hematology Association (EHA), Sagar Lonial, MD, of the Winship Cancer Institute, Emory University, Atlanta, GA…
30 Jul 2015
Thrombosis in Haematological Disorders: Tailored Management Approaches
The meeting commenced with a talk from Prof Anna Falanga on the management of thrombosis in both onco-haematological and non-oncological diseases.
30 Jul 2015
Why Biosimilars Matter: An Innovative Solution to Improve Patient Access
The meeting was introduced by Prof Robin Foà who spoke about the difficulties for patients Prof Foà opened the symposium by highlighting…
Loading posts...
« Previous
1
…
92
93
94
95
96
…
100
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View